Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Digital Therapeutics: Everything You Need to Know
Summary
In this episode, Tom Caravela welcomes Madleine Makori to discuss her career journey and passion for the MSL role, with a particular focus on digital therapeutics. Madleine shares insights into the differentiation and challenges of digital therapeutics and how COVID-19 has accelerated technology adaptation for patient populations. The conversation delves into the growing collaborations in digital therapeutics and the increasing provider interest in this field. Madleine highlights expanding opportunities for MSLs in tech and the importance of education in this evolving area. The episode concludes with an invitation for audience engagement and a call to subscribe.
Madleine Makori, Sr Medical Science Liaison at Big Health discusses everything you need to know about Digital Therapeutics
Maddy explains…
π What is Digital Therapeutics and how it differs from wellness and lifestyle apps
π How Digital Therapeutics is making an impact on the pharmaceutical industry
π The impact of Covid-19 and the development of the space
π What opportunities may emerge and what it means for Medical Affairs
π What the future looks like for the Digital Therapeutics space and what people need to know
Digital Therapeutics, Medical Science Liaison, COVID-19 technology adaptation, opportunities in tech for MSLs, future of Digital Therapeutics
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
Over-Negotiation-How to Botch a Job Offer
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois
Sponsorship of oncology clinical trials in the United States according to age of eligibility
Article
Michael Z. Liao, Dan Lu, Matts KΓ₯gedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
Article
Karen Geary